Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating HBI-8000 in combination with nivolumab for melanoma, renal cell carcinoma, and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Results: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of pegylated IL-10 (pegilodecakin) in adults with advanced solid tumors; results from a first-in-human trial assessing safety …
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma [Phase 1, Phase 2]
Clinical trial results for a recombinant vaccinia virus in combination with cemiplimab in renal cell carcinoma have been completed, with res…
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab plus lenvatinib for brain metastases from melanoma or renal cell carcinoma; study terminated with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) [Phase 3]
Phase 3 clinical study evaluating belzutifan and zanzalintinib in recurrent renal cell carcinoma after adjuvant therapy is in recruitment.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Aerosolized Aldesleukin in Treating Patients With Lung Metastases [Phase 1]
Phase 1 study evaluating aerosolized aldesleukin (interleukin-2) in patients with cancers that have metastasized to the lung, including mela…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial examining perioperative lenvatinib with pembrolizumab in locally advanced nonmetastatic clear cell renal cell carcinoma; resul…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers [Phase 2]
Phase 2 trial of AUR 109 in ovarian cancer, colorectal cancer, and renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]
A completed Phase 2 trial evaluating sunitinib in patients with metastatic kidney cancer, including brain metastases. The update notes compl…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: ITIL-306 in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of ITIL-306 in advanced solid tumors sponsored by Instil Bio has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Follow-up After Metastasectomy in Patients With Kidney Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating follow-up after metastasectomy in patients with renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer
A terminated clinical trial assessed whether differences in sunitinib bioavailability influence treatment toxicity and efficacy in patients …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" [NA]
The EMBARC trial assessing embolization before ablation for renal cell carcinoma (RCC) has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update investigates pembrolizumab in combination with aflibercept in patients with advanced cancers, including melanoma, col…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Clinical trial evaluating cabozantinib in elderly patients with metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) [Phase 2]
Phase 2 clinical trial update for belzutifan (PT2977, MK-6482) in Von Hippel-Lindau disease-associated renal cell carcinoma; the study (NCT0…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry
The SMART Registry, a study of minimally-invasive ablative renal therapies for renal cell carcinoma, is currently suspended. Sponsor is the …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors [Phase 1]
Phase 1 update reporting safety, pharmacokinetics, and preliminary efficacy data for AI-061 in advanced solid tumors across multiple indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1 Study of the Safety and Tolerability of CTX-10726 [Phase 1]
Phase 1 study update on the safety and tolerability of CTX-10726, currently recruiting across gastroesophageal cancer, hepatocellular carcin…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) [Phase 2]
Phase 2 study compares subcutaneous pembrolizumab coformulated with hyaluronidase alfa (MK-3475A) to intravenous pembrolizumab in multiple t…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: CBCT Guided Markerless SBRT for Renal Cell Cancer [NA]
A clinical trial evaluating CBCT-guided markerless SBRT for renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…